UBS analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on February 23, 2026.
HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $526.52 with a market capitalization of $117.1B.
reiterateNYSE:HCA
UBS Reiterates Buy Rating on HCA Healthcare, Inc. (HCA)
UBS analysts reiterated a Buy rating on HCA Healthcare, Inc. (NYSE:HCA) on February 23, 2026. HCA Healthcare, Inc.
